ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $1.34B

      Shares

      10.4M

      % of Portfolio

      0.97%

      Average Buy Price

      $62.4

      Avg closing price
      Price range

      50 PRIMECAP Management Novartis AG Trades

      PRIMECAP Management's position in Novartis AG is currently worth $1.34B. That's 0.97% of their equity portfolio (31st largest holding). The first Novartis AG trade was made in Q1 2013. Since then PRIMECAP Management bought shares eleven more times and sold shares on 38 occasions. The stake costed the investor $649M, netting the investor a gain of 106% so far.

      Avg closing price
      Price range
      Increased shares by 0.2% (+18.6k shares) Q2 2025
      Avg closing price $112.73
      Price range $101.96 - $121.01
      Sold 5.8% shares (-642k shares) Q1 2025
      Avg closing price $106.19
      Price range $97.14 - $115.57
      Sold 8.2% shares (-983k shares) Q4 2024
      Avg closing price $106.36
      Price range $97.06 - $117.18
      Sold 1.4% shares (-171k shares) Q3 2024
      Avg closing price $113.48
      Price range $106.13 - $120.89
      Sold 1.9% shares (-238k shares) Q2 2024
      Avg closing price $100.38
      Price range $92.57 - $107.37
      Sold 3.8% shares (-488k shares) Q1 2024
      Avg closing price $102.53
      Price range $95.27 - $108.47
      Sold 11.6% shares (-1.69M shares) Q4 2023
      Avg closing price $96.53
      Price range $92.27 - $101.54
      Sold 2.8% shares (-416k shares) Q3 2023
      Avg closing price $101.51
      Price range $94.73 - $105.13
      Sold 8.6% shares (-1.42M shares) Q2 2023
      Avg closing price $100.02
      Price range $92.52 - $104.91
      Sold 4.5% shares (-768k shares) Q1 2023
      Avg closing price $87.33
      Price range $80.03 - $92.81
      Sold 1.5% shares (-258k shares) Q4 2022
      Avg closing price $84.23
      Price range $75.31 - $92.53
      Sold 0.9% shares (-151k shares) Q3 2022
      Avg closing price $82.89
      Price range $74.61 - $87.43
      Sold 1.0% shares (-181k shares) Q2 2022
      Avg closing price $87.73
      Price range $80.52 - $93.75
      Sold 2.1% shares (-381k shares) Q1 2022
      Avg closing price $86.58
      Price range $80.11 - $90.62
      Sold 4.7% shares (-896k shares) Q4 2021
      Avg closing price $83.03
      Price range $79.70 - $88.13
      Sold 1.1% shares (-220k shares) Q3 2021
      Avg closing price $89.96
      Price range $81.78 - $95.14
      Sold 6.1% shares (-1.26M shares) Q2 2021
      Avg closing price $89.05
      Price range $85.24 - $94.15
      Sold 5.8% shares (-1.26M shares) Q1 2021
      Avg closing price $89.74
      Price range $83.50 - $98.47
      Sold 3.4% shares (-765k shares) Q4 2020
      Avg closing price $87.38
      Price range $78.07 - $94.43
      Sold 3.0% shares (-696k shares) Q3 2020
      Avg closing price $86.63
      Price range $82.14 - $91.00

      News about Novartis AG - ADR and PRIMECAP Management

      Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys?AG's Minority Shareholders

      Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys?AG's Minority Shareholders

      PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 20, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announces that Novartis BidCo Germany AG informed the MorphoSys...

      accesswire.com accesswire.com, about 1 year ago
      Novartis AG (NYSE:NVS) Stock Position Lowered by Empire Financial Management Company LLC

      Novartis AG (NYSE:NVS) Stock Position Lowered by Empire Financial Management Company LLC

      Empire Financial Management Company LLC lessened its ¡­ shares during the quarter. Empire Financial Management Company LLC¡¯s holdings ¡­

      EIN News Finance EIN News Finance, almost 2 years ago
      Applied Finance Capital Management LLC Raises Stock Position in Novartis AG (NYSE:NVS)

      Applied Finance Capital Management LLC Raises Stock Position in Novartis AG (NYSE:NVS)

      ¡­ of two business units: Novartis Oncology and Novartis Pharmaceuticals . See Also Receive News ¡­ & Ratings for Novartis Daily - ¡­ and analysts'' ratings for...

      EIN News Pharmaceuticals EIN News Pharmaceuticals, almost 2 years ago
      Top 5 4th Quarter Trades of Veriti Management LLC

      Top 5 4th Quarter Trades of Veriti Management LLC

      Related Stocks: NIO , META , AMZN , NVS , TTM ,

      GuruFocus GuruFocus, over 2 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×